These mRNA vaccines efficiently delivered TAA-encoding mRNA to DCs and subsequently activated antitumor CD8+ and CD4+ T-cell immune responses, reduced tumor-associated immunosuppression, and finally significantly decreased tumor growth and metastasis in different murine tumor models [43,55,56,57,58,59,60,61,62]. This evidence concerns the gene CD4 and neoplasm.